GAITHERSBURG, MD – October 9, 2025 – miRecule, Inc. today announced that Dr. Hunter Wallace will present data from its collaboration with Sanofi at the 21st Annual Meeting of the Oligonucleotide Therapeutics Society (OTS) in Budapest, Hungary. The presentation will highlight a novel RNA therapeutic approach for Facioscapulohumeral Muscular Dystrophy (FSHD).
The poster, titled “Targeting DUX4 mRNA with anti‑TfR NANOBODY® antisense oligonucleotide conjugates,” will be presented on Monday, October 20, 2025 (Poster P‑245).